OphthoBook by Dr Timothy Root presents a concise, approachable, and freely accessible introduction to ophthalmology aimed at medical students, junior doctors, and allied health professionals. Rather than attempting to replicate the breadth of traditional ophthalmology textbooks, the book adopts a focused educational philosophy: to distil the specialty into its most clinically relevant components and present them clear and digestible style.

Brittle cornea syndrome (BCS) is a rare autosomal recessive connective tissue disorder. It is characterised by progressive corneal thinning, corneal ectasia, blue sclera, and marked ocular fragility. These features lead to a significantly increased risk of spontaneous or traumatic corneal perforation. The condition was first described by Stein et al. in 1968 during an attempted surgical repair of a corneal perforation. During suturing, the cornea was observed to fragment easily, highlighting its extreme fragility. The syndrome was later further characterised by Ticho et al., who reported the association of brittle cornea with blue sclera and red hair. In contrast to other connective tissue disorders with ocular involvement, BCS primarily affects the cornea rather than the sclera. This distinction is clinically important, as it has implications for diagnosis, management, and prognosis.

Herpes zoster (HZ) is caused by reactivation of latent varicella zoster virus (VZV) within sensory ganglia. This reactivation is named as herpes zoster ophthalmicus (HZO) when it occurs in the ophthalmic branch (V1) of the trigeminal nerve. HZO begin with a typical dermatomal rash. However, it can progress to keratitis, anterior uveitis, secondary glaucoma, neurotrophic keratopathy, and rarely posterior segment involvement. It can cause permanent vision loss in severe cases. Early identification, systemic antiviral therapy, and appropriate follow up can reduce morbidity and visual impairment.

The primary goals of anaesthesia for cataract surgery are to provide adequate analgesia, minimise patient anxiety and movement, and facilitate rapid postoperative recovery. Although general anaesthesia was historically the standard approach, it is now rarely used and is reserved for selected patients, including children, individuals with cognitive impairment, severe anxiety or claustrophobia and those with significant head tremor. Advances in phacoemulsification, foldable intraocular lenses and microincision techniques have driven a shift towards regional and topical anaesthetic approaches. Consequently, most cataract procedures are now performed as day-case surgeries under local anaesthesia.

Eye presentations are frequent in general practice, but many referrals are delayed or less effective because key examination findings aren’t documented. Particularly visual acuity and “red flag” features. Quality improvement work in primary care shows that simple prompts and a standardised approach can markedly improve documentation of high-yield findings.

Graves’ orbitopathy (GO), also called thyroid eye disease, is the most common extrathyroidal manifestation of Graves’ disease. The European Group on Graves’ Orbitopathy (EUGOGO) is an international, multidisciplinary scientific society with a goal of improving the care of patients with GO. It’s multicentric network contributes towards a better understanding of GO, its pathogenesis, newer therapies and their translation into clinical practice by carrying out large randomised controlled trials (RCT). Evidence-based data is combined to create treatment recommendations.

Optic disc coloboma is a rare congenital anomaly of the optic nerve head caused by partial or complete failure of closure of the embryonic fissure. It is characterised by a sharply demarcated, bowl-shaped excavation that replaces part of the optic disc. The defect most commonly involves the inferior nasal aspect of the disc and may extend to involve the retina, uvea, and sclera.

Central serous chorioretinopathy (CSCR) is a chorioretinal disorder defined by serous detachment of the neurosensory retina. The disease commonly involves the macula. The disease most commonly affects young to middle-aged adults. It represents a major cause of central visual complaints in people between the ages of 35-55. CSCR is usually a self-limiting condition. However, chronic or recurrent disease can cause persistent visual symptoms and irreversible changes to the retinal pigment epithelium (RPE) and outer retina. New developments in retinal imaging have significantly evolved understanding of CSCR pathophysiology. It is currently recognised primarily as a disorder of choroidal vascular dysfunction within the pachychoroid disease spectrum, instead of a condition stemming from RPE abnormalities.

Albinism encompasses a group of heterogenous genetic conditions affecting the melanin synthesis pathway leading to a reduction or absence in melanin production. In ophthalmology, albinism can be broadly categorised into two groups: oculocutaneous albinism (OCA) and ocular albinism (OA). In OCA, hypopigmentation involves the skin, hair, and eyes, whereas in OA pigmentary changes are limited to ocular structures, primarily the iris and retina. Both OA and OCA are rare disorders that share similar characteristic ocular findings and visual challenges. This article focuses on oculocutaneous albinism.

An FY2 rotation offers a unique opportunity to address this gap, it allows foundation doctors to develop focused history taking and clinical examination skills. This helps build confidence in managing both acute and chronic ophthalmic conditions. These skills are transferable across general practice, emergency medicine, and a range of medical and surgical specialties.